Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
It can be administered at an IV dose of up to 1000mg/week
Large clinical trials and post-marketing surveillance have found no increased thyroid cancer incidence in GLP-1 users
Diabetes Care 26 , 23702377 (2003)
Incretin-based therapies should be avoided during pregnancy and are contraindicated in those with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia 2A or 2B because some studies found a possible increased risk of thyroid cancer with the use of GLP-1 receptor agonists
In contrast, we have found that thigh injections may be susceptible to bruising in some individuals due to the thigh being a thicker muscle region with a greater density of blood vessels
Patient Hope Patients waiting for retatrutide are a combination of hopeful and cautious
US$ 28.61
US$ 27.42
US$ 26.69
US$ 22.56
US$ 28.63
US$ 22.45
US$ 23.39
US$ 29.02
US$ 28.80
US$ 21.02
US$ 26.54
US$ 27.61
